AI assistant
Sending…
METLIFE INC — Director's Dealing 2025
Mar 13, 2025
29995_dirs_2025-03-13_52f31c43-4875-4516-99e1-425bd4d2e2c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2025-03-11
Reporting Person: Kennard William E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-11 | Common Stock | A | 291 | $78.45 | Acquired | 42199 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10 | Indirect |
Footnotes
F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.
F2: Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.
More from METLIFE INC
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Director's Dealing
2026
Mar 19